期刊文献+

DCP、AFP-L3和AFP在原发性肝细胞癌诊断中的价值 被引量:8

Diagnostic Value of Des-gamma Carboxyprothrombin(DCP),Lectin-bound AFP(AFP-L3) and Alpha-fetoprotein(AFP) Expression in Primary Hepatocellular Carcinoma
下载PDF
导出
摘要 目的:探讨血清中脱γ一羧基凝血酶原(DCP)、甲胎蛋白异质体(AFP-L3)和甲胎蛋白(AFP)对原发性肝细胞癌(PHC)单独和联合诊断的意义,为PHC诊治提供一种新方法,以及对高危人群作筛选。方法:采集53例PHC、51例肝硬化、60例慢性肝炎和52例健康对照者的血清分别检测DCP、AFP-L3和AFP,并对其统计分析。结果:PHC患者的DCP、AFP-L3和AFP均显著高于肝硬化、慢性肝炎和健康对照者,DCP、AFP-L3和AFP在PHC组中的灵敏度分别为77.36%、69.8 1%和60.38%,特异性分别为89.57%、88.34%和77.91%。三者联检时,其诊断的敏感度可提高至94.34%。结论:DCP对PHC诊断具有较好的敏感度和特异性,联检DCP、AFP-L3和AFP可有效提高PHC尤其是AFP阴性PHC的诊断效率,对PHC的早期诊治具有一定指导意义。 Objective To observe the alone and joint diagnostic value of des-gamma carboxyprothrombin (DCP), lectin-bound AFP(AFP-L3) and alpha-fetoprotein(AFP) in primary hepatocellular carcinoma, and provide a novel method for diagnosis for PHC and screening for high risk population. Methods The levels of serum DCP, AFP-L3 and AFP were measured in 53 patients with hepa- toceUular carcinoma, $1 cases of cirrhosis, 60 cases of chronic hepatitis, 52 normal healthy subjects established as control group, and analyse the result statistically. Results The levels of serum DCP,AFP-L3 and AFP were significantly higher in the hepatocellular carcinoma than those in other groups. The diagnostic sensitivities of DCP, AFP-L3 and AFP to hepatocellular carcinoma were 77.36%, 69.81% and 60.38% respectively, the specificity were 89.57%, 88.34% and 77.91%, individually. The joint detection could improve sensitivity up to 94.34%. Conclusion DCP was a high sensitivity and specificity marker for diagnosis of PHC. The combined assay of serum tumor markers possess more value in the diagnosis of PHC, especially in AFP negative patients.
出处 《放射免疫学杂志》 CAS 2013年第1期75-78,共4页 Journal of Radioimmanology
关键词 原发性肝细胞癌 甲胎蛋白 脱γ一羧基凝血酶原 甲胎蛋白异质体 primary hepatocellular carcinoma ( PHC), alpha-fetoprotein ( AFP), des-gamma carboxyprothrombin ( DCP), alpha-fetoprotein variant( AFP-L3 )
  • 相关文献

参考文献10

  • 1李永利,马洪滨,郭静霞,史佳彬,徐军,刘爱霞,杨丽华,李伯安,毛远丽.甲胎蛋白异质体L3预警原发性肝癌的研究[J].中华实验和临床病毒学杂志,2008,22(5):336-338. 被引量:32
  • 2袁联文,唐伟,李永国,幕内雅敏.脱-γ-羧基凝血酶原:一种有用的血清肝癌标志物[J].中华普通外科杂志,2004,19(8):506-506. 被引量:11
  • 3Lopez JB. Recent developments in the first detection of hepatocel- lular carcinoma[ J]. Clin Biochem Rev, 2005, 26 (3): 65-79.
  • 4Choi J, Park Y, Kim JH, et al. Evaluation of revisited fucosylated alpha-fetoprotein(AFP-L3) with an autoanalyzer txTAS in a clinical labo- ratory[J]. Clin Chim Acta, 2012, 413(1-2) : 170-174.
  • 5Tamura Y, Igarashi M, Suda T, et al. Fucosylated fraction of al- pha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment [ J ]. Dig Dis Sci, 2010, 55 ( 7 ) : 2095-2101.
  • 6Kanke F, Kumada T, Toyoda H, et al. Reference change values for lens culinaris agglutinin-reactive t-fetopretein and des-/-carboxy pro- thrombin in patients with chronic hepatitis C[J]. Clin Chem Lab Med, 2012,50 (5) :957-960.
  • 7SterlingPK, WrightEC, MorganTR, etal. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C[J]. Am J Gastroenterol, 2012, 107(1) :64-74.
  • 8张国庆,王斌,刘振疆,黄艳春,庞作良.AFP、AFP-L_3和AFU联合检测在原发性肝癌诊断中的应用[J].新疆医科大学学报,2005,28(2):150-152. 被引量:9
  • 9V olk ML, Hernandez JC, Su GL, et al. Risk factors for hepatocel- lular carcinoma may impair the performance of biomarkers : a comparison of AFP, DCP, and AFP-L3[J]. Cancer Biomark, 2007, 3(2) :78-87.
  • 10Kumada T, Toyoda H, Kiriyama S, et al. Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus [J]. J Gastroeuterol,2011,46(4) :536-544.

二级参考文献19

  • 1青柳豊,韩少良.甲胎蛋白(AFP)L3组分[J].日本医学介绍,2005,26(2):49-50. 被引量:37
  • 2王永忠,罗立波,吴国祥,陈敏,阮丽花,濮翔科,杭双荣.微量离心柱法分离检测甲胎蛋白异质体(AFP-L3)及其临床意义[J].中华实验和临床病毒学杂志,2007,21(2):135-137. 被引量:19
  • 3武田和久 藤香 等.AFP的糖链分析在肝癌诊断上的应用[J].国外医学:临床生物化学与检验学分册,1990,11(2):28-28.
  • 4Hu KQ, Kyulo NL. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol, 2004,99 : 860-865.
  • 5Yoshida S, Kurokohchi K, Arims K, et al. Clinical significance of lens culinaris agglutinin-revctiae fraction of serum alpha-fetoprotein in oatients with hepatocellular carcinoma. Int J Oncol, 2002,20 : 105-111.
  • 6Li D, Mallory T. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta,2001,313:15-19.
  • 7FDA. Class Ⅱ Special Controls Guidance Document: AFP-L3% Immunological Test Systems Document Issued on October 4,2005.
  • 8汤钊猷.现代肿瘤学[M](第2版)[M].上海:上海医科大学出版社,2001.553.
  • 9Oka H, Saito A, Ito K, et al. Muhieenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of lens eulinaris agglutinin- reactive alpha-fetoprotein [J]. J Gastroenterol Hepatol,2001,16 : 1378-1383.
  • 10Purves LR, Merwe VE, Bersohn I, et al. Variants of α-fetoprotein[J]. Lancet, 1970,2 : 464.

共引文献49

同被引文献101

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部